Anavex Life Sciences Corp (AVXL)

[blu_1]

This is not true. Missling said at Lartenburg, as well as the AAIC poster summary, that dosings are still 10-50mg through at least 31 weeks. clinicaltrials.gov said last month only 25% of subjects are on 50mg.

DZP stymies 273 I am convinced. Just look at the 7 only on 273 vs 273+dzp scores. DZP competitively competes with 273 for sigma sites and it has MUCH greater affinity for those sites than 273. DZP counters 273's agonism of the M1 receptor b/c it is a M1 antagonist. A paper even wrote that M1 antagonists cancel out drugs that agonize M1. Look at DZP's affect on TauRx's drug permformance, which targets M1. It cancels out TauRx's drug.